Reviewer: Jeremy Steinberg, GP Registrar, RNZCGP
Date of review: October 2017
Comments: This app is most useful for headache sufferers and their doctors. It is a very basic tracking of headaches allowing some help with diagnosis and treatment. Although logging a headache is simple and fast, the app has many shortfalls and clinically is of very poor quality. When the app asks you to record the headache diagnosis (e.g. migraine, sinus, tension), does not allow for “unknown,” and misses some headache types anyway. This could lead to error and misdirection if using the app to aid in diagnosis and therapeutic management. Unless the patient was very well educated on headache diagnosis or was a doctor themselves. It does not include many important headache features such as associated symptoms (e.g. nausea). Cannot customise headache details. Cannot export results with free version. No headache information.
Safety concerns: Would not identify potentially sinister headache features due to limited questions.
New Zealand relevance: Formigran is not available in New Zealand. Erroneously lists aspirin twice, once as its chemical name acetylsalicylic acid and once with German spelling asperin.
Formal MARS Review
The formal app review is based on the Mobile App Rating Scale (MARS) developed by researchers at Queensland University of Technology, Australia.(1) It is designed to score apps on a few comprehensive dimensions — engagement, functionality, aesthetics, and information quality. Each dimension comprises several items which are rated on a 5-point scale from “1. Inadequate” to “5. Excellent”.
Read more about the MARS scale(external link).
The mean score is the mean of two independent reviewers' ratings:
|Engagement (5 items)||3.2|
|Functionality (4 items)||3.7|
|Aesthetics (3 items)||2.8|
|Information (7 items)||3.1|
|App quality mean score||3.2|
- Stoyanov SR, Hides L, Kavanagh DJ, et al. Mobile app rating scale: a new tool for assessing the quality of health mobile apps(external link). JMIR Mhealth Uhealth. 2015 Mar 11;3(1):e27. doi: 10.2196/mhealth.3422.